Sydenham chorea is a post-streptococcal, autoimmune, neuropsychiatric, movement disorder. There is no effective treatment. In a randomized study, comparison was made of the outcomes of 10 children treated with standard management alone compared to 10 who received additional intravenous immunoglobulin. The outcomes were assessed using a clinical rating scale, brain single-photon emission computed tomography, and the duration of symptomatic treatment. All three outcome measurement tools found improved outcomes in the group that received intravenous immunoglobulin.
MooreDP.Neuropsychiatric aspects of Sydenham’s chorea: a comprehensive review. J Clin Psychiatry. 1996;57(9):407–414.
2.
GarveyMASwedoSE.Sydenham’s chorea clinical and therapeutic update. Adv Exp Med Biol. 1997;418:115–120.
3.
Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268(15):2069–2073.
4.
JonesT.Diagnosis of rheumatic fever. JAMA. 1944;126:481–484.
5.
AronAMFreemanJMCarterS.The natural history of Sydenham’s chorea. Am. J. Med. 1965;38:83–94.
6.
AsbahrFRGarveyMASniderLAZanettaDMElkisHSwedoSE.Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry. 2005;57(9):1073–1076.
7.
AsbahrFRNegraoABGentilV. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998;155(8):1122–1124.
8.
SwedoSE.Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272(22):1788–1791.
9.
WalkerKLawrensonJWilmshurstJ.Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol. 2005;47:771–775.
10.
WalkerKLawrensonJWilmshurstJM.Sydenham’s chorea—clinical and therapeutic update 320 years down the line. S Afr Med J. 2006;96(9):906–912.
11.
WalkerKGWilmshurstJM.An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010;3(5):301–309.
12.
CarapetisJRCurrieBJ.Rheumatic chorea in northern Australia: a clinical and epidemiological study. Arch Dis Child. 1999;80(4):353–358.
13.
van ImmerzeelTDvan GilstRMHartwigNG.Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr. 2010;169(9):1151–1154.
14.
HusbyGVan de RinjIZabriskieJBAbdinAHWilliamsRC.Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;114:1094–1110.
15.
GarveyMASniderLALeitmanSFWerdenRSwedoSE.Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20(5):424–429.
16.
ChurchAJCardosoFDaleRCLeesAJThompsonEJGiovannoniG.Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002;59(2):227–231.
17.
ChurchAJDaleRCCardosoF. CSF and serum immune parameters in Sydenham’s chorea: evidence of an autoimmune syndrome?. J Neuroimmunol. 2003;136(1-2):149–153.
18.
VossLMWilsonNJNeutzeJM. Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation. 2001;103(3):401–406.
19.
CilliersAMManyembaJSaloojeeH.Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev. 2003;(2):CD003176.
20.
DiabKATimaniMABitarFF.Treatment of rheumatic carditis with intravenous gammaglobulin: is there a beneficial effect?. Cardiol Young. 2001;11(5):565–567.
KabakusNBalciTAKurtAKurtAN.Cerebral blood flow abnormalities in children with Sydenham’s chorea: a SPECT study. Indian Pediatr. 2006;43(3):241–246.
25.
CitakECGucuyenerKKarabacakNISerdarogluAOkuyazCAydinK.Functional brain imaging in Sydenham’s chorea and streptococcal tic disorders. J Child Neurol. 2004;19(5):387–390.
26.
DemirorenK.Functional brain imaging in Sydenham’s chorea. J Child Neurol. 2006;21(6):544–545.
27.
DilengeMEShevellMIDinhL.Restricted unilateral Sydenham’s chorea: reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning. J Child Neurol. 1999;14(8):509–513.
28.
WilesCMBrownPChapelH. Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry. 2002;72(4):440–448.
29.
RobertsonKAVolminkJAMayosiBM.Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa—the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J. 2006;96(3):241–245.
30.
MayosiBRobertsonKVolminkJ. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J. 2006;96(3 Pt 2):246.
TeixeiraALJrMaiaDPCardosoF.The initial testing and the discrimination property of the UFMG Sydenham’s Chorea Rating Scale (USCRS). Arq Neuropsiquiatr. 2005;63(3B):825–827.
33.
GowersWR.On paralytic chorea. Br Med J. 1881;1(1060):636–637.
34.
CilliersAM.Rheumatic fever and its management. BMJ. 2006;333:1153–1156.
35.
ShenkerDMGrossmanHJKlawansHL.Treatment of Sydenham’s chorea with haloperidol. Dev Med Child Neurol. 1973;15:19–24.
36.
WalkerARTaniLYThompsonJAFirthSDVeasyLGBaleJFJr.Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr. 2007;151(6):679–683.
37.
PastoreSDe CuntoABenettoniABertonETaddioALeporeL.The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford). 2011;50(2):396–400.
38.
Al-EissaA.Sydenham’s chorea: a new look at an old disease. Br J Clin Pract. 1993;47(1):14–16.
PazJASilvaCAMarques-DiasMJ.Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34(4):264–269.
41.
TeixeiraALCardosoFMaiaDPCunninghamMC.Sydenham’s chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry. 2003;74(9):1350–1351.
42.
NausiedaPABieliauskasLABaconLDHagertyMKollerWCGlantzRN.Chronic dopaminergic sensitivity after Sydenham’s chorea. Neurology. 1983;33(6):750–754.
43.
EdgarTS.Oral pharmacotherapy of childhood movement disorders. J Child Neurol. 2003;18:840–849.
44.
MarijonECelermajerDSTaffletM. Rheumatic heart disease screening by echocardiography: the inadequacy of World health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009;120:663–668.
45.
NiehausDJKnowlesJAvan KradenbergJ. D8/17 in obsessive-compulsive disorder and trichotillomania. S Afr Med J. 1999;89(7):755–756.
46.
WalkerKGCooperMMcCabeK. Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Cardiol Young. 2011;1–6.
